You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,093,732


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,093,732
Title:Antagonists of IL-6 to prevent or treat thrombosis
Abstract: The present invention is directed to therapeutic methods using IL-6 antagonists such as antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat thrombosis in diseases associated with abnormal blood coagulation or fibrinolysis. In preferred embodiments these patients will comprise those exhibiting elevated D-dimer or other coagulation cascade related proteins and optionally will further exhibit elevated C reactive protein prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, et al.
Inventor(s): Smith; Jeffrey T. L. (Bellevue, WA)
Assignee: ALDERBIO HOLDINGS LLC (Las Vegas, NV)
Application Number:14/933,141
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 10,093,732

Introduction

United States Patent 10,093,732, like any other patent, is a complex document that requires a thorough analysis to understand its claims, implications, and position within the broader patent landscape. This analysis will delve into the key aspects of the patent, including its claims, the process of obtaining it, and its relevance in the current technological and legal environment.

Understanding the Patent Claims

What are Patent Claims?

Patent claims are the heart of any patent application, defining the scope of the invention and what is protected by the patent. For US Patent 10,093,732, the claims would outline the specific features and limitations of the invention, determining what constitutes infringement and what does not[2].

Analyzing the Claims of US Patent 10,093,732

To analyze the claims of this patent, one must import the patent document and parse the claims into their hierarchical structure. Tools like the Patent Matrix software can facilitate this process by automating the import, parsing, and compression of claims, making it easier to review and understand the complex hierarchy of claims[2].

The Patent Application Process

Filing and Examination

The process of obtaining a patent involves filing an application with the United States Patent and Trademark Office (USPTO) and undergoing a rigorous examination. The examiner reviews the application to determine if the claims are novel, non-obvious, and useful, comparing them against prior art[4].

File Wrappers and Prosecution History

The file wrapper or prosecution history of a patent application contains detailed interactions between the applicant and the examiner, including arguments, amendments, and prior art citations. This information is crucial for understanding the legal status and the technological context of the invention. For US Patent 10,093,732, analyzing the file wrapper would provide insights into how the claims were narrowed or modified to overcome examiner objections[4].

Subject Matter Eligibility

The Alice/Mayo Framework

Patent applications, especially those involving software and AI inventions, must pass the subject matter eligibility test under 35 U.S.C. ยง 101. The USPTO uses a two-pronged framework (Step 2A) to determine eligibility, focusing on whether the claims recite an abstract idea and whether they provide a practical application or technological improvement[3].

Practical Applicability Analysis

For AI inventions, demonstrating a specific, concrete technological advancement is crucial under Prong Two of the framework. This involves showing that the claims are directed to a solution to a technical problem, rather than just an abstract idea. Effective arguments under this prong require a deep understanding of the technological field and the ability to persuade the examiner that the claims offer a practical application[3].

Oversight and Independence of PTAB Judges

The Role of PTAB

The Patent Trial and Appeal Board (PTAB) is an adjudicative body within the USPTO that provides an alternative to federal courts for resolving patent disputes. PTAB judges decide whether to institute trials and determine the validity of patents. However, there have been concerns about the independence of these judges due to oversight practices by USPTO directors and PTAB management[1].

Impact on Decision-Making

A significant majority of PTAB judges have reported that management oversight affects their independence, particularly in discretionary decisions such as whether to institute a trial. This oversight can influence judges' decisions without necessarily affecting the merits of the case, highlighting a need for clearer policies and procedures to ensure judicial independence[1].

Competitive Intelligence and Patent Landscape Analysis

Using File Wrappers

File wrappers are a valuable tool for competitive intelligence, providing detailed insights into the patent application process and the arguments made between applicants and examiners. By analyzing these documents, one can understand the strengths and weaknesses of a patent and its position within the broader patent landscape[4].

Prior Art and Citation Analysis

The Common Citation Document (CCD) application consolidates prior art citations from multiple patent offices, facilitating a comprehensive analysis of the patent landscape. This tool helps in identifying key prior art references and understanding how different offices evaluate the same invention, which is essential for strategic patent management[5].

Legal and Regulatory Environment

Guidance Updates and Judicial Precedents

The USPTO issues periodic guidance updates to clarify patent subject matter eligibility, but these guidelines are not binding on the judicial branch. The Federal Circuit has emphasized that judicial precedents, such as those from the Supreme Court, take precedence over USPTO guidance. This dynamic highlights the importance of staying updated with both administrative and judicial developments in patent law[3].

Practical Applications and Technological Advancements

Technological Innovation and Patent Protection

The increasing number of patent applications, driven by technological innovation, underscores the importance of effective patent protection. Patents attract capital for development and commercialization, and tools like automated patent claims analysis systems are crucial for managing the complexity of modern patent applications[2].

Key Takeaways

  • Patent Claims Analysis: Understanding the hierarchical structure and scope of patent claims is essential for determining the protection and limitations of a patent.
  • Patent Application Process: The examination process involves rigorous review against prior art, and file wrappers provide valuable insights into the prosecution history.
  • Subject Matter Eligibility: Demonstrating practical applicability and technological improvement is critical for overcoming section 101 rejections.
  • PTAB Oversight: The independence of PTAB judges is a concern, with management oversight potentially influencing discretionary decisions.
  • Competitive Intelligence: Analyzing file wrappers and prior art citations is vital for understanding the patent landscape and making strategic decisions.
  • Legal and Regulatory Environment: Staying updated with both administrative guidelines and judicial precedents is crucial for navigating patent law.

FAQs

Q: What is the significance of file wrappers in patent analysis?

File wrappers contain detailed interactions between the applicant and the examiner, providing insights into the arguments, amendments, and prior art citations that shaped the final patent. This information is essential for understanding the legal status and technological context of the invention.

Q: How does the USPTO's two-pronged framework impact AI patent applications?

The two-pronged framework under Step 2A of the Alice/Mayo test requires AI patent applications to demonstrate a practical application or technological improvement. This involves showing that the claims are directed to a specific, concrete technological advancement, which is critical for overcoming section 101 rejections.

Q: What are the concerns regarding PTAB judges' independence?

A significant majority of PTAB judges have reported that oversight by USPTO directors and PTAB management affects their independence, particularly in discretionary decisions such as whether to institute a trial.

Q: How can the Common Citation Document (CCD) application aid in patent landscape analysis?

The CCD application consolidates prior art citations from multiple patent offices, facilitating a comprehensive analysis of the patent landscape. This tool helps in identifying key prior art references and understanding how different offices evaluate the same invention.

Q: Why is it important to stay updated with both USPTO guidance and judicial precedents?

USPTO guidance does not carry the force of law, and judicial precedents from the Federal Circuit and the Supreme Court take precedence. Staying updated with both ensures compliance with the latest legal interpretations and avoids potential conflicts.

Sources

  1. GAO Report: "Patent Trial and Appeal Board: Preliminary Observations on Oversight Practices and Policies" - GAO-22-106121.
  2. Patent Claims Analysis System: "US20110138338A1 - Patent Claims Analysis System and Method".
  3. Baker Botts: "The Importance of Prong Two of Step 2A for AI Inventions".
  4. IP Checkups: "Patent file wrappers as a tool for competitive intelligence".
  5. USPTO: "Search for patents - USPTO".

More… ↓

⤷  Subscribe

Details for Patent 10,093,732

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch Health Us, Llc IPRIVASK desirudin For Injection 021271 April 04, 2003 10,093,732 2028-11-25
Janssen Biotech, Inc. REOPRO abciximab Injection 103575 December 22, 1994 10,093,732 2028-11-25
Genentech, Inc. RITUXAN rituximab Injection 103705 November 26, 1997 10,093,732 2028-11-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.